Search results
Sask. man who didn't want his daughter to get COVID-19 shots found guilty of abduction
CBC via Yahoo News· 5 days agoJackson said he believed the
Man dies after 613-day COVID-19 infection that underwent 50 mutations
AOL· 2 days agoAccording to the study, the man, whose identity was not disclosed, suffered from a blood disorder....
Police investigate 'suspicious package' in downtown Austin; road reopens
FOX 7 Austin· 10 hours agoThe Austin Police Department investigated a suspicious package in downtown Austin.
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 1 day agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 2 days agoThe bulk of long COVID research carried out over the past four years has attempted to understand the...
U.S. Could Vaccinate a Fifth of Americans in a Bird Flu Emergency
Barrons.com· 4 days agoAnthony Fauci, then the director of the National Institute of Allergy and Infectious Diseases,...
72-year-old patient had COVID for record 613 days, accumulated over 50 mutations from virus before...
NY Post via Yahoo News· 5 days agoWhile most people can overcome the coronavirus in a few weeks, anything medical professionals tried...
COVID-19 booster immunity lasts much longer than primary series alone, study shows
Medical Xpress· 6 days agoThe study used Canadian vaccine data collected from individuals living in long-term care, as well as frontline health-care workers working in long-term care and hospitals.
How to get vaccines to remote areas? In Sierra Leone they’re delivered by foot, boat or motorbike
The Conversation· 6 days agoThis is one of the key reasons why COVID-19 vaccination rates in the country are low. During an innovative vaccine programme mobile & ...
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial forCovid-19 Booster Vaccine
Morningstar· 6 days agoBy Chris Wack Imunon shares rose after the company received clearance from the U.S. Food and Drug Administration to begin a Phase 1 clinical trial with a seasonal Covid-< ...